Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JAB-8263 in Active Rheumatoid Arthritis
NCT07684157Phase 2Recruiting
- Sponsor
- Jacobio Pharmaceuticals
- Start
- Jul 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of jab-8263 in rheumatoid arthritis (RA), sponsored by Jacobio Pharmaceuticals. Started Jul 2026; status: recruiting.
02
Drugs
jab-8263
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07684157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07684157.